degraders and further highlight the importance of selecting suitable E3 members to achieve effective cellular activity.
Zhang X, He Y, Zhang P, Budamagunta V, Lv D, Thummuri D, Yang Y, Pei J, Yuan Y, Zhou D, Zheng G. (2020). PROTACs as potent degraders across multiple cancer cell lines. European journal of medicinal chemistry, (199)